<DOC>
	<DOCNO>NCT02024269</DOCNO>
	<brief_summary>This open-label , non-randomized multi-center study adipose stem cell ( ASC ) implantation . ASCs derive patient 's adipose fat . Liposuction use local anesthesia syringe collection perform collect adipose tissue specimen subsequent process isolate stem cell . The cell deliver via needle injection eye .</brief_summary>
	<brief_title>Study Assess Safety Effects Cells Injected Intravitreal Dry Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<criteria>Males Females Age 50 90 year Patients dry AMD Visual acuity study eye &lt; 20200 ( equal bad 20/200 ) Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Inability undergo syringe liposuction procedure medical problem contraindicate procedure . Life expectancy &lt; 6 month due concomitant illness . Vitrectomized eye Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . . If patient test positive HIV , HTLV , HBV , HCV , CMV ( IgM &gt; IgG ) and/or syphilis , expert consult patient eligibility base patient 's infectious status Any illness might affect patient 's survival followup period Any illness , Investigator 's judgement , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Patients severe coagulation disorder Systolic blood pressure ( supine ) â‰¤90 mmHg ; Resting heart rate &gt; 100 bpm ; Active clinical infection treat antibiotic within one week enrollment . Cerebrovascular accident within 6 month prior study entry Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . Severe COPD severe asthma would contraindicate surgery History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last two year . Unwilling and/or able give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>macular degeneration</keyword>
	<keyword>stem cell</keyword>
	<keyword>adipose stem cell</keyword>
</DOC>